Invuity, Inc., a San Francisco, CA-based developer of advanced medical devices, secured $36m in Series E financing.
The round, which is a combination of $21m in equity and up to $15m in debt, was led by HealthCare Royalty Partners, along with existing investors Valence Life Sciences, InterWest Partners, Kleiner Perkins Caufield and Byers, and a number of other investors.
The company intends to use the funds to accelerate commercial initiatives across its product line of devices for minimally invasive surgery.
Led by Chief Executive Officer Philip Sawyer, Invuity develops advanced medical devices to improve access and visualization in minimally invasive and minimal access surgeries. The company’s products incorporate its proprietary Eigr technology into sophisticated hand-held illumination devices and access systems for a variety of surgical specialties including spine, orthopedics, breast and thyroid oncology and plastic surgery.
FinSMEs
04/03/2014
Related News
14/06/2012: Invuity Closes $25M Series D Financing